Russell Investments Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $325K | Buy |
2,517
+426
| +20% | +$61.2K | ﹤0.01% | 2676 |
|
|
2025
Q4 | $298K | Sell |
2,091
-123
| -6% | -$16.5K | ﹤0.01% | 2681 |
|
|
2025
Q3 | $266K | Buy |
2,214
+1,969
| +804% | +$249K | ﹤0.01% | 2709 |
|
|
2025
Q2 | $32.4K | Hold |
245
| – | – | ﹤0.01% | 3081 |
|
|
2025
Q1 | $34K | Sell |
245
-393
| -62% | -$61K | ﹤0.01% | 2994 |
|
|
2024
Q4 | $99K | Buy |
638
+300
| +89% | +$50.7K | ﹤0.01% | 2692 |
|
|
2024
Q3 | $61.6K | Sell |
338
-133
| -28% | -$19.7K | ﹤0.01% | 2751 |
|
|
2024
Q2 | $55.9K | Sell |
471
-75
| -14% | -$7.89K | ﹤0.01% | 2739 |
|
|
2024
Q1 | $58.6K | Buy |
546
+173
| +46% | +$17.2K | ﹤0.01% | 2647 |
|
|
2023
Q4 | $37.2K | Hold |
373
| – | – | ﹤0.01% | 2669 |
|
|
2023
Q3 | $44.4K | Sell |
373
-1,358
| -78% | -$203K | ﹤0.01% | 2769 |
|
|
2023
Q2 | $308K | Hold |
1,731
| – | – | ﹤0.01% | 2365 |
|
|
2023
Q1 | $286K | Sell |
1,731
-201
| -10% | -$34.6K | ﹤0.01% | 2403 |
|
|
2022
Q4 | $304K | Sell |
1,932
-458
| -19% | -$69.7K | ﹤0.01% | 2455 |
|
|
2022
Q3 | $358K | Hold |
2,390
| – | – | ﹤0.01% | 2365 |
|
|
2022
Q2 | $391K | Sell |
2,390
-200
| -8% | -$38.5K | ﹤0.01% | 2342 |
|
|
2022
Q1 | $574K | Buy |
2,590
+1,998
| +338% | +$448K | ﹤0.01% | 2174 |
|
|
2021
Q4 | $139K | Sell |
592
-832
| -58% | -$194K | ﹤0.01% | 2790 |
|
|
2021
Q3 | $331K | Sell |
1,424
-116
| -8% | -$24.3K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $315K | Sell |
1,540
-8,815
| -85% | -$1.81M | ﹤0.01% | 2765 |
|
|
2021
Q1 | $2.13M | Sell |
10,355
-38,046
| -79% | -$8.03M | ﹤0.01% | 1843 |
|
|
2020
Q4 | $10.4M | Sell |
48,401
-31,874
| -40% | -$6.18M | 0.02% | 836 |
|
|
2020
Q3 | $14.7M | Buy |
80,275
+1,790
| +2% | +$337K | 0.03% | 597 |
|
|
2020
Q2 | $14.4M | Buy |
78,485
+55,430
| +240% | +$11M | 0.03% | 575 |
|
|
2020
Q1 | $4.65M | Buy |
23,055
+16,945
| +277% | +$3.26M | 0.01% | 1001 |
|
|
2019
Q4 | $1.14M | Buy |
6,110
+4,526
| +286% | +$779K | ﹤0.01% | 2037 |
|
|
2019
Q3 | $253K | Sell |
1,584
-4,291
| -73% | -$854K | ﹤0.01% | 2524 |
|
|
2019
Q2 | $1.48M | Sell |
5,875
-7,432
| -56% | -$1.72M | ﹤0.01% | 1815 |
|
|
2019
Q1 | $3.18M | Sell |
13,307
-698
| -5% | -$167K | 0.01% | 1481 |
|
|
2018
Q4 | $3.21M | Sell |
14,005
-14,391
| -51% | -$3.55M | 0.01% | 1350 |
|
|
2018
Q3 | $8.02M | Sell |
28,396
-2,764
| -9% | -$810K | 0.02% | 1047 |
|
|
2018
Q2 | $9.15M | Buy |
31,160
+10,241
| +49% | +$2.8M | 0.02% | 963 |
|
|
2018
Q1 | $5.28M | Buy |
20,919
+5,132
| +33% | +$1.21M | 0.01% | 1341 |
|
|
2017
Q4 | $3.42M | Sell |
15,787
-484
| -3% | -$98K | 0.01% | 1541 |
|
|
2017
Q3 | $3.02M | Buy |
16,271
+200
| +1% | +$34.9K | 0.01% | 1543 |
|
|
2017
Q2 | $2.77M | Sell |
16,071
-6,972
| -30% | -$1.12M | ﹤0.01% | 1544 |
|
|
2017
Q1 | $3.52M | Sell |
23,043
-44,993
| -66% | -$6.58M | 0.01% | 1426 |
|
|
2016
Q4 | $9.87M | Buy |
+68,036
| New | +$9.85M | 0.02% | 860 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Russell Investments Group's ICUI Position: Q1 2026 in Review
Russell Investments Group increased its ICU Medical (ICUI) stake by 20% in Q1 2026, buying an estimated $61.2K and bringing the position to 2,517 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.
Russell Investments Group first reported a position in ICUI in Q4 2016 and has held it in 38 quarters since. The position peaked at $14.7M in Q3 2020. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Russell Investments Group held 2,517 shares of ICU Medical worth $325K as of Q1 2026.
- Russell Investments Group bought 426 ICU Medical shares in Q1 2026, an estimated $61.2K.
- ICU Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2676 holding.
- Russell Investments Group first reported a position in ICU Medical in Q4 2016 and has held it in 38 quarters since.
- Russell Investments Group's ICU Medical position peaked at $14.7M in Q3 2020.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.